Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-28
2006-11-28
Siew, Jeffrey (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C536S023100
Reexamination Certificate
active
07141543
ABSTRACT:
The present invention relates to the discovery of novel genes encoding RIEG polypeptides. Therapeutics, diagnostics and screening assays based on these molecules are also disclosed.
REFERENCES:
patent: 5460950 (1995-10-01), Barr et al.
patent: 6518411 (2003-02-01), Murray et al.
1994-1995 Promega Catalog, p. 167.
Amendt, Brad A. , et al. “The Molecular Basis of Rieger Syndrome”,J. Biol Chem. vol. 273. Issue 32. 20066-20072. Aug. 7, 1998.
Frisch, et al., “A Soluble Immunoglobin Variable Domain Without A Disultide Bridge . . . ”,Biol. Chem Hoppe-Seyler. vol. 375. pp. 353-356. 1994.
Gordon, D. F., et al., “Human Cart -1: Structural Organization, Chromosomal Localization, and Functional Analysis of Cartilage-Specific Homeodomain cDNA”.DNA Cell Biol., 15(7): 531-541, 1996.
Kim, et al. “Restoring Allosterism with Compensatory Mutations in Hemoglobin”PNAS. vol. 91. pp. 11547-11551. Nov. 1994.
Lamonerie, T. et al., “Ptx1. a Biocoid-related Homeo Box Transcription Factor Involved in Transcription of the Pro-Opiomelanocortin Gene.”.Genes&Development10: 1284-1295. 1996.
Matthews, B. “Genetic and Structural Anaylsis of the Protein Stability Problem”.Perspectives in Biochemistry. Hans Neurath. Ed., vol. 1. pp. 6-9. 1989.
Matthews and VanHolde, Biochemistry. (Textbook). 2ndedition. pp. 165-171. 1996.
Semina, E. V., et al. “Cloning and Characterization of a Novel Human Homeobox Gene Involved in the Reiger Syndrome and Its Mouse Homolog” (ABSTRACT)American J. of Human Genetics. vol. 59, #4 (suppl.) p. A9, No. 34. Oct. 1996.
Semina, Elena V., et al., Cloning and Characterization of a Novel Biocoid-related Homeobox Transcription Factor Gene. RIEG. involved in Rieger Syndrome.Nature Geneticsvol. 14. Dec. 1996.
Szeto, Daniel P., et al., “P-OTX: A PIT-1 interacting Homeodomain Factor Expressed During Anterior Pituitary Gland Development”.PNAS. vol. 93. pp. 7706-7710, Jul. 1996.
Yishi Jin, et al. Control of Type-D GABAergic Neuron Differentiation by C. elegans UNC-30 Homeodomain Protein.Nature. vol. 372. Dec. 22/29, 1994.
Hillier, I . . . et al., GENBANK Accession No. T64905. Mar. 7, 1995.
Hillier, I . . . et al., GENBANK Accession No. H95407. Nov. 25, 1996.
Hillier, I . . . et al., GENBANK Accession No. H13139, Jun. 27, 1995.
Hillier, I . . . et al., GENBANK Accession No. AA102052, Oct. 28, 1996.
Marra, M et al. GENBANK Accession No. W59350, Jun. 6, 1996.
Marra, M et al. GENBANK Accession No. W77302, Jun. 20, 1996.
Marra, M et al, GENBANK Accession No. AA032943, Aug. 22, 1996.
Semina, E. V., et al., GENBANK Accession No. U69961. Dec. 19, 1996.
Wright, D. A., et al. GENBANK Accession No. U15276. Oct. 11, 1994.
Murray Jeffrey C.
Semina Elena
Fetterolf Brandon
Foley & Hoag LLP
Siew Jeffrey
University of Iowa Research Foundation
LandOfFree
RIEG compositions and therapeutic and diagnostic uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RIEG compositions and therapeutic and diagnostic uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RIEG compositions and therapeutic and diagnostic uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3673062